Dr. George Poste
About
Dr. George Poste serves as Chief Executive Officer of consulting company, Health Technology Networks, which specializes in the application of genomic technologies and computing in healthcare.
History
Dr. Poste assumed Directorship of The Complex Adaptive Systems Initiative (CASI) (http://www.casi.asu.edu/) in March 2009 (ASU announces new research initiative July 14, 2008, George Poste, director of the Biodesign Institute July 14, 2008, will lead the new Complex Adaptive Systems Initiative at ASU July 14, 2008 Poste to lead transformational initiative at ASU July 25, 2008). This program links expertise across the university in research on synthetic biology, ubiquitous sensing, healthcare informatics for personalized medicine and advanced computing for non-linear dynamics.
From 2003 to 2009 he was Director of the Biodesign Institute at ASU (www.biodesign.asu.edu/). In leading this Institute, Dr. Poste designed and built 400,000 sq. ft. of new facilities, achieved cumulative research funding of $225 million and recruited over 60 faculty, including three members of the National Academies of Science and Engineering (Biodesign Institute Accomplishments).In addition to his academic post he serves on the Board of Directors of Monsanto (since February 2003), Exelixis (since August 2004), Caris Life Sciences (since 2005), and the Scientific Advisory Board of Synthetic Genomics. From 1992 to 1999 he was Chief Science and Technology Officer and President, R&D of SmithKline Beecham (SB). During his tenure at SB he was associated with the successful registration of 31 drug, vaccine and diagnostic products. In 2004 he was named as ‘R&D Scientist of the Year’ by R&D Magazine, in 2006 he received the Einstein award from the Global Business Leadership Council and in 2009 received the Scrip Lifetime Achievement award voted by the leadership of the global pharmaceutical industry.
He has published over 350 research papers and edited 14 books on pharmaceutical technologies and oncology. Most recently in an invited commentary published in the January 13 issue of Nature titled Bring on the biomarkers, George Poste, Chief Scientist for ASU’s Complex Adaptive Systems Initiative, makes a case for replacing the current patchwork of fragmented research on disease-associated biomarkers with a coordinated ‘big science’ approach. Biomarkers are molecular changes in body tissues and fluids that signal the presence of a disease. Read the article. He has received honorary degrees in science, law and medicine for his research contributions and was honored in 1999 by HM Queen Elizabeth II as a Commander of the British Empire for his contributions to international security.
He is a Fellow of the Royal Society, the Royal College of Pathologists and the UK Academy of Medicine, a Distinguished Fellow at the Hoover Institution, Stanford University and a member of the Council for Foreign Relations. From 2003 to 2009 he was a member of the Defense Science Board of the US Department of Defense (DoD). He continues to serve on US government advisory boards related to national security, intelligence, terrorism and healthcare. He is a member of the US Institute of Medicine Board on Global Health.
His personal interests are in automobile racing, military history, photography and exploring the deserts of the American Southwest.
